Interventions addressing primary care attachment and upstream social determinants may improve early detection and access to curative therapy in lung cancer stage at diagnosis and surgical treatment persist in Ontario.
Abstract
Lung cancer is the leading cause of cancer mortality in Canada, with most cases diagnosed at advanced stage. Despite universal healthcare, social determinants of health may impact stage at diagnosis and access to treatment. We examined the association between these factors, stage at diagnosis, and receipt of surgery in Ontario. We conducted a population-based retrospective cohort study of adults diagnosed with lung cancer in Ontario from 2007–2023 using linked administrative health data. Stage was obtained from the Ontario Cancer Registry. Factors included income, primary care attachment, immigration status, geographic region, and distance to the nearest cancer centre. Logistic regression identified factors associated with stage IV diagnosis. Among 106,867 patients with available stage data, 52.6% were diagnosed with stage IV disease; 19.1% were stage I. Patients without a family physician were significantly more likely to present with stage IV cancer compared with those fully rostered (62.1% vs 51.5%; adjusted OR 1.55, p < 0.001). Females had lower likelihood of stage IV diagnosis than males (OR 0.85, p < 0.001). Increasing household income was associated with reduced likelihood of stage IV disease (OR 0.92 for highest vs lowest quintile, p < 0.001). Immigrants were less likely to be diagnosed with stage IV cancer than non-immigrants (OR 0.77, p = 0.001). Frailty was associated with higher odds of stage IV disease (OR 1.01, p = 0.009). Surgical resection was performed in 56.1% of patients with stage I disease and 1.4% with stage IV disease. Receipt of surgery decreased with advancing age (27.0% < 50 years vs 7.3% ≥ 80 years), higher comorbidity burden (25.4% with 0 vs 5.0% with ≥5 comorbidities), and lack of primary care attachment. Marked social inequities in lung cancer stage at diagnosis and surgical treatment persist in Ontario. Interventions addressing primary care attachment and upstream social determinants may improve early detection and access to curative therapy.
It was found that prolonged DTIs to be significantly associated with poorer survival, but cautious interpretation of the results is needed given the potential impact of the waiting time paradox.
M. Jalink, W. King, Christopher M. Booth et al.· Cancer Epidemiology· 0 citations
Although several disparities were partly explained by comorbidity and BMI, others persisted, highlighting the need for targeted strategies to reduce differences between SEP groups in rectal cancer management and outcomes.
S. D. de Vries, F. V. van Erning, M. Aarts et al.· International Journal of Can...· 0 citations
Two critical barriers to effective lung cancer screening are emphasized: the limited reach of existing eligibility criteria and inadequate uptake of low-dose CT.
M. Sharifian, Alvin Tran, Omar Cespedes-Gomez et al.· Journal of the American Coll...· 0 citations
The findings suggest that efforts to shorten DTI may improve patient survival in this population of patients with stage I non-adenocarcinoma NSCLC treated with SBRT in Ontario.
Cassidy Laub, Paul Nguyen, M. Jalink et al.· McMaster University Medical...· 0 citations
DFS in cervical cancer is strongly influenced by tumor burden and locoregional spread, and the early decline in survival highlights the need for intensive follow-up during the first two years post-treatment.
Bajarang Bahadur, S. Choudhary, Deshna Oswal et al.· Frontiers in Oncology· 0 citations
Substantial geographic variation exists in the demographic and socioeconomic profile of patients with melanoma, which may correlate to meaningful differences in stage at diagnosis and, given melanoma’s strongly stage-dependent prognosis, potentially survival outcomes as well.
Lola Fuentes Brock, B. Demirors, Nikhil Godbole et al.· Anticancer Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.